Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRent ExpenseResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Avricore Health (AVCRF) Shares Outstanding (Weighted Average) (2016 - 2025)

Avricore Health has reported Shares Outstanding (Weighted Average) over the past 12 years, most recently at $19.6 million for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) fell 72.73% to $19.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.6 million through Dec 2025, down 72.73% year-over-year, with the annual reading at $19.5 million for FY2025, 73.33% down from the prior year.
  • Shares Outstanding (Weighted Average) was $19.6 million for Q4 2025 at Avricore Health, down from $73.6 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $77.4 million in Q4 2021 and troughed at $19.6 million in Q4 2025.
  • The 5-year median for Shares Outstanding (Weighted Average) is $73.6 million (2024), against an average of $68.4 million.
  • Year-over-year, Shares Outstanding (Weighted Average) soared 82.61% in 2021 and then plummeted 73.01% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $77.4 million in 2021, then decreased by 6.83% to $72.1 million in 2022, then increased by 1.44% to $73.1 million in 2023, then dropped by 1.81% to $71.8 million in 2024, then crashed by 72.73% to $19.6 million in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Shares Outstanding (Weighted Average) are $19.6 million (Q4 2025), $73.6 million (Q3 2025), and $19.7 million (Q2 2025).